Search

Your search keyword '"Peter P, De Deyn"' showing total 113 results

Search Constraints

Start Over You searched for: Author "Peter P, De Deyn" Remove constraint Author: "Peter P, De Deyn"
113 results on '"Peter P, De Deyn"'

Search Results

1. Noradrenaline release from the locus coeruleus shapes stress-induced hippocampal gene expression

2. Small vessel disease burden and functional brain connectivity in mild cognitive impairment

Catalog

Books, media, physical & digital resources

3. Alzheimer’s disease pattern derived from relative cerebral flow as an alternative for the metabolic pattern using SSM/PCA

4. Validation and test–retest repeatability performance of parametric methods for [11C]UCB-J PET

5. Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils

6. Amyloid-β1–43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations

7. A Systematic Review on the Effects of Different Types of Probiotics in Animal Alzheimer's Disease Studies

8. Brain Kynurenine Pathway Metabolite Levels May Reflect Extent of Neuroinflammation in ALS, FTD and Early Onset AD

9. Peculiarities in the Amino Acid Composition of Sow Colostrum and Milk, and Their Potential Relevance to Piglet Development

10. Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer’s disease

11. Feasibility of pharmacokinetic parametric PET images in scaled subprofile modelling using principal component analysis

12. Amyloid burden quantification depends on PET and MR image processing methodology.

13. Widespread white matter aberration is associated with the severity of apathy in amnestic Mild Cognitive Impairment: Tract-based spatial statistics analysis

14. Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective

15. Lipocalin 2 contributes to brain iron dysregulation but does not affect cognition, plaque load, and glial activation in the J20 Alzheimer mouse model

16. Adherence to driving cessation advice given to patients with cognitive impairment and consequences for mobility

17. Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis

18. Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early‐onset Alzheimer's disease

19. Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models

20. Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum

21. Optimization of the k2′ Parameter Estimation for the Pharmacokinetic Modeling of Dynamic PIB PET Scans Using SRTM2

22. Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target

23. Inducing Physical Inactivity in Mice: Preventing Climbing and Reducing Cage Size Negatively Affect Physical Fitness and Body Composition

24. Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer’s Disease

25. Subtle alterations in cerebrovascular reactivity in mild cognitive impairment detected by graph theoretical analysis and not by the standard approach

26. Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome

27. Noradrenaline release from the locus coeruleus shapes stress-induced hippocampal gene expression

28. The validation of Short Interspersed Nuclear Elements (SINEs) as a RT-qPCR normalization strategy in a rodent model for temporal lobe epilepsy.

29. Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies.

31. De BPSD-DS evaluatieschaal voor dementiegerelateerde gedragsveranderingen bij mensen met downsyndroom

32. Lower Choline and Myo-Inositol in Temporo-Parietal Cortex Is Associated With Apathy in Amnestic MCI

33. Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes

34. De relatie tussen apathie, depressie en cognitief functioneren bij patiënten met MCI en dementie

35. Associating Alzheimer’s disease pathology with its cerebrospinal fluid biomarkers

36. Tau promotes oxidative stress-associated cycling neurons in S phase as a pro-survival mechanism : possible implication for Alzheimer’s disease

37. Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method

38. Detectie en preventie van kwetsbaarheid: Op zoek naar risicoprofielen voor fysieke, psychische, sociale en omgevingskwetsbaarheid

39. Increased White Matter Inflammation in Aging- and Alzheimer’s Disease Brain

40. Dementia in People with Severe/Profound Intellectual (and Multiple) Disabilities: Practice-Based Observations of Symptoms

41. A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer's disease mouse model

42. Dementia in People with Severe/Profound Intellectual (and Multiple) Disabilities: Applicability of Items in Dementia Screening Instruments for People with Intellectual Disabilities

43. Sinus Sigmoideus Thrombosis Secondary to Graves’ Disease:A Case Description

44. Plasma 5‐HIAA activity indicative of serotonergic disturbances in cognitively impaired, elderly patients experiencing postoperative delirium

45. Crossed Aphasia and Visuo-Spatial Neglect Following a Right Thalamic Stroke: A Case Study and Review of the Literature

46. Disrupted Auto-Activation, Dysexecutive and Confabulating Syndrome Following Bilateral Thalamic and Right Putaminal Stroke

47. Validation and test-retest repeatability performance of parametric methods for [

48. Kinetics and 28-day test-retest repeatability and reproducibility of [

49. Planning in amnestic mild cognitive impairment: an fMRI study

50. Contribution of homozygous and compound heterozygous missense mutations in VWA2 to Alzheimer's disease